Literature DB >> 20148104

Acute effect of smoking on plasma Obestatin levels.

Asterios Kukuvitis1, Marios Froudarakis, Stavros Tryfon, Argyris Tzouvelekis, Maria Saroglou, Nikolaos Karkavitsas, Demosthenes Bouros.   

Abstract

BACKGROUND: Smoking and smoking cessation are considered to be associated with weight changes. We have recently shown that smoking acutely increases plasma levels of ghrelin, a known orexigenic hormone. Obestatin is a peptide encoded by the ghrelin gene, which opposes ghrelin effects on food intake. We conducted a study in adult volunteers measuring plasma levels of obestatin immediately after initiation of smoking.
METHODS: 31 volunteers (mean age 32.2 +/- 9.2 years and mean BMI 25.7 +/- 4.1), 17 smokers and 14 non-smokers, were enrolled in our study. The 2 groups were matched in age and BMI. Plasma obestatin concentrations were determined at baseline (T0), 2 (T2), 5 (T5), 15 (T15), and 60 (T60) minutes after the initiation of smoking.
RESULTS: In all 31 subjects, no significant difference in the mean values of plasma obestatin levels was observed from baseline at T2, T5, T15 and T60 after initiation of smoking (overall p = 0.15). However, a trend for higher obestatin levels was noted in smokers vs non-smokers (overall p = 0.069), which was not related to the pack-years.
CONCLUSION: On the contrary with ghrelin's response after smoking initiation, there is no such an acute response of plasma obestatin levels.

Entities:  

Year:  2010        PMID: 20148104      PMCID: PMC2819234          DOI: 10.1186/1617-9625-8-2

Source DB:  PubMed          Journal:  Tob Induc Dis        ISSN: 1617-9625            Impact factor:   2.600


  11 in total

1.  Smoking acutely increases plasma ghrelin concentrations.

Authors:  Demosthenes Bouros; Argyris Tzouvelekis; Stavros Anevlavis; Michael Doris; Stavros Tryfon; Marios Froudarakis; Vasiliki Zournatzi; Asterios Kukuvitis
Journal:  Clin Chem       Date:  2006-04       Impact factor: 8.327

2.  Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.

Authors:  Daisuke Yamamoto; Nobuko Ikeshita; Rie Daito; Elizabeth Henny Herningtyas; Keizo Toda; Kentaro Takahashi; Keiji Iida; Yutaka Takahashi; Hidesuke Kaji; Kazuo Chihara; Yasuhiko Okimura
Journal:  Regul Pept       Date:  2006-10-19

3.  Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.

Authors:  Philippe Zizzari; Romaine Longchamps; Jacques Epelbaum; Marie Thérèse Bluet-Pajot
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

4.  The ongoing saga of obestatin: is it a hormone?

Authors:  Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2007-09       Impact factor: 5.958

5.  Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome.

Authors:  Won Hah Park; Yoo Joung Oh; Gae Young Kim; Sang Eun Kim; Kyung-Hoon Paik; Sun Ju Han; An Hee Kim; Su Hyun Chu; Eun Kyung Kwon; Seon Woo Kim; Dong-Kyu Jin
Journal:  J Clin Endocrinol Metab       Date:  2006-10-17       Impact factor: 5.958

Review 6.  One ancestor, several peptides post-translational modifications of preproghrelin generate several peptides with antithetical effects.

Authors:  Oreste Gualillo; Francisca Lago; Felipe F Casanueva; Carlos Dieguez
Journal:  Mol Cell Endocrinol       Date:  2006-07-07       Impact factor: 4.102

Review 7.  Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

Authors:  G Gourcerol; D H St-Pierre; Y Taché
Journal:  Regul Pept       Date:  2007-01-12

8.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

9.  Circulating preprandial ghrelin to obestatin ratio is increased in human obesity.

Authors:  Zhi-Fu Guo; Xing Zheng; Yong-Wen Qin; Jian-Qiang Hu; Shao-Ping Chen; Zheng Zhang
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

Review 10.  Smoking cessation and weight gain.

Authors:  C Filozof; M C Fernández Pinilla; A Fernández-Cruz
Journal:  Obes Rev       Date:  2004-05       Impact factor: 9.213

View more
  1 in total

Review 1.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.